Coordinating center clinical trials "oxytocin for alcohol use disorder" task order no. 8 - HHSN275201400001I/HHSN27500008 title: oxytocin for alcohol use disorder period of performance: july 12,…

Ended Awarded Last action

Contract number
HHSN27500008
Awardee
Awarding agency
Obligated
$8,206,354

Award facts

Contract value 100% obligated
$8,206,353.79 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute on Alcohol Abuse and Alcoholism National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
North Potomac, MD, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 · Clinical trial to test oxytocin for treatment alcohol use disorder $0
Other Administrative Action P00008 · Clinical trial to test oxytocin for treatment alcohol use disorder -- modification to allow for electronic delivery only of identified deliverables $0
Change Order P00007 · Change order and equitable adjustment to clinical trial -- oxytocin for alcohol use disorder $2,580,857
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · Clinical trial -- oxytocin for alcohol use disorder $0
Other Administrative Action P00001 $0
Original award $5,625,497
Show all 14

About this award

This is a task order award under a larger indefinite delivery, indefinite quantity (IDIQ) contract with the Department of Health and Human Services' National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism (NIAAA). The task order, valued at $8,206,353.79, is for a cost-plus-fixed-fee clinical trial to examine the use of oxytocin for the treatment of alcohol use disorder. The prime contractor is Fast-Track Drugs & Biologics, L.L.C., a woman-owned small business. The period of performance is from July 12, 2017 through July 11, 2019, with a total estimated completion date of June 30, 2024. This task order was not set aside for any type of small business. Fast-Track Drugs & Biologics also holds a separate $14 million total small business set-aside IDIQ contract with NIAAA to coordinate multiple clinical trials for alcohol use disorder treatments.

Description

Coordinating center clinical trials "oxytocin for alcohol use disorder" task order no. 8 - HHSN275201400001I/HHSN27500008 title: oxytocin for alcohol use disorder period of performance: july 12, 2017 through july 11, 2019 type of contract: cost plus fixed fee (non-severable services)

Quick answers

Who was awarded contract HHSN27500008?

HHSN27500008 was awarded to Fast-Track Drugs & Biologics, L.L.C. by National Institute of Child Health and Human Development (National Institutes of Health) on July 11, 2017.

How much is contract HHSN27500008 worth?

The government has obligated $8,206,354 on HHSN27500008.

Which agency awarded contract HHSN27500008?

National Institute of Child Health and Human Development (National Institutes of Health) awarded HHSN27500008, with funding from National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health).

Is contract HHSN27500008 an order under another contract?

Yes. HHSN27500008 is a delivery order under HHSN275201400001I, an indefinite delivery contract.

Was contract HHSN27500008 competed?

The extent of competition for HHSN27500008 was full and open competition after exclusion of sources.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award